Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gastric Cancer

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 132 articles: HTML format

Single Articles

April 2024
1. BHANDARE MS, Gundavda KK, Yelamanchi R, Chopde A, et al
   Impact of pCR after neoadjuvant chemotherapy and radical D2 dissection in locally advanced gastric cancers: Analysis of 1001 cases.
   Eur J Surg Oncol. 2024;50:108343.
   PubMed     Abstract available
   
   
   
2. COSTA PMD, Antunes C, Lages P, Rodrigues J, et al
   Challenging the Dogma: Stage migration or negative lymph nodes, which of them is the main player on gastric cancer prognosis?
   Eur J Surg Oncol. 2024;50:108318.
   PubMed     Abstract available
   
   
   
3. SHEEN AR, Saqib HWU
   "Harnessing AI for treatment optimization: Neoadjuvant chemotherapy in gastroesophageal cancer".
   Eur J Surg Oncol. 2024;50:108228.
   PubMed    
   
   
   
4. KUHLEN M, Kunstreich M, Pape UF, Seitz G, et al
   Lymph node metastases are more frequent in paediatric appendiceal NET >/=1.5 cm but without impact on outcome - Data from the German MET studies.
   Eur J Surg Oncol. 2024;50:108051.
   PubMed     Abstract available
   
   
   
5. VAN HOOTEGEM SJM, Chmelo J, van der Sluis PC, Lagarde SM, et al
   The yield of diagnostic laparoscopy with peritoneal lavage in gastric adenocarcinoma: A retrospective cohort study.
   Eur J Surg Oncol. 2024;50:108233.
   PubMed     Abstract available
   
   
   
6. MAURER CA, Walensi M, Mattiello D, Kaser SA, et al
   Intraoperative esophageal washout reduces free intraluminal tumor cells during resection of carcinomas of the esophagus and cardia.
   Eur J Surg Oncol. 2024;50:108017.
   PubMed     Abstract available
   
   
   March 2024
7. HUANG ZN, Zheng CY, Wu J, Tang YH, et al
   Textbook oncological outcomes and prognosis after curative gastrectomy in advanced gastric cancer: A multicenter study.
   Eur J Surg Oncol. 2024;50:108280.
   PubMed     Abstract available
   
   
   
8. VAN DER SLUIS K, Guchelaar NAD, Triemstra L, Mathijssen RHJ, et al
   Staging laparoscopy in gastric cancer patients: From a Dutch nationwide Delphi consensus towards a standardized protocol.
   Eur J Surg Oncol. 2024;50:108278.
   PubMed     Abstract available
   
   
   
9. HUANG B, Rampulla V, Ri M, Lindblad M, et al
   Staging laparoscopy with peritoneal lavage to identify peritoneal metastases and free intraperitoneal cancer cells in the management of locally advanced gastric cancer.
   Eur J Surg Oncol. 2024;50:108059.
   PubMed     Abstract available
   
   
   
10. LIN X, Tan C, Wu W, Liang C, et al
    Evaluation of factors influencing long-term and textbook outcomes in laparoscopic gastrectomy.
    Eur J Surg Oncol. 2024;50:108002.
    PubMed     Abstract available
    
    
    February 2024
11. NOOR Z, Gossage J, Evans O, Cuffe R, et al
    Unmet needs in survivorship: Increased anxiety post oesophago-gastric cancer surgery.
    Eur J Surg Oncol. 2024;50:108046.
    PubMed     Abstract available
    
    
    
12. LI J, Chen X, Xu S, Wang Y, et al
    Predicting pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer: The establishment of a spectral CT-based nomogram from prospective datasets.
    Eur J Surg Oncol. 2024;50:108020.
    PubMed     Abstract available
    
    
    
13. ZHENG HL, Wei LH, Xu BB, Zheng HH, et al
    Prognostic value of preoperative sarcopenia in gastric cancer: A 10-year follow-up study.
    Eur J Surg Oncol. 2024;50:108004.
    PubMed     Abstract available
    
    
    January 2024
14. TAKI Y, Ito S, Mizusawa J, Yura M, et al
    Risk factors for abdominal surgical infectious complications after distal gastrectomy for gastric cancer: A post-hoc analysis of a randomized controlled trial (JCOG0912).
    Eur J Surg Oncol. 2024;50:107982.
    PubMed     Abstract available
    
    
    December 2023
15. MIAO X, Guo Y, Chen Y, Xu X, et al
    Exploration of frailty trajectories and their associations with health outcomes in older gastric cancer survivors undergoing radical gastrectomy: A prospective longitudinal observation study.
    Eur J Surg Oncol. 2023;50:107934.
    PubMed     Abstract available
    
    
    
16. YAO GL, Tao YJ, Fan YG
    Cutaneous metastasis from gastric cancer: Manifestation, diagnosis, treatment and prognosis.
    Eur J Surg Oncol. 2023;50:107939.
    PubMed     Abstract available
    
    
    
17. MENG C, Cao S, Yu Q, Tian Y, et al
    Short- and long-term comparison of robotic versus laparoscopic gastrectomy for gastric cancer patients with BMI>/=30 kg/m(2): A propensity score matched analysis.
    Eur J Surg Oncol. 2023;50:107312.
    PubMed     Abstract available
    
    
    
18. HOJO Y, Ishida Y, Tomita T, Kurahashi Y, et al
    Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer.
    Eur J Surg Oncol. 2023;50:107314.
    PubMed     Abstract available
    
    
    
19. TRIEMSTRA L, de Jongh C, Tedone F, Brosens LAA, et al
    The Comprehensive Complication Index versus Clavien-Dindo grading after laparoscopic and open D2-gastrectomy in the multicenter randomized LOGICA-trial.
    Eur J Surg Oncol. 2023;49:107095.
    PubMed     Abstract available
    
    
    November 2023
20. MINISTRINI S, Bencivenga M, Filippini F, Mura G, et al
    A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series.
    Eur J Surg Oncol. 2023;50:107275.
    PubMed     Abstract available
    
    
    
21. HOLMEN A, Jebril W, Ida S, Agustsson T, et al
    Effects of neoadjuvant therapy on health-related quality of life for patients with gastroesophageal cancer.
    Eur J Surg Oncol. 2023;49:107008.
    PubMed     Abstract available
    
    
    
22. KANG MK, Kim J, Choi JH, Choe HN, et al
    Can prospective monitoring improve complication rates after gastrectomy? Experience of Billroth I reconstruction at a high-volume tertiary center.
    Eur J Surg Oncol. 2023;49:106985.
    PubMed     Abstract available
    
    
    
23. HUANG ZN, Huang YQ, Hong QQ, Zhang P, et al
    Long-term prognostic benefit of adjuvant chemotherapy for patients with hepatoid adenocarcinoma of the stomach after radical resection: A national multicenter study.
    Eur J Surg Oncol. 2023;49:106975.
    PubMed     Abstract available
    
    
    
24. SALAVATIZADEH M, Soltanieh S, Radkhah N, Ataei Kachouei AH, et al
    The association between skeletal muscle mass index (SMI) and survival after gastrectomy: A systematic review and meta-analysis of cohort studies.
    Eur J Surg Oncol. 2023;49:106980.
    PubMed     Abstract available
    
    
    October 2023
25. ZHANG J, Cao X, Dai N, Zhu S, et al
    Efficacy analysis of endoscopic treatment of giant gastric gastrointestinal stromal tumors (>/=5 cm).
    Eur J Surg Oncol. 2023;49:106955.
    PubMed     Abstract available
    
    
    
26. WITHEY SJ, Owczarczyk K, Grzeda MT, Yip C, et al
    Association of dynamic contrast-enhanced MRI and (18)F-Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer.
    Eur J Surg Oncol. 2023;49:106934.
    PubMed     Abstract available
    
    
    September 2023
27. ZHENG CY, Wu J, Chen CS, Huang ZN, et al
    A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter study.
    Eur J Surg Oncol. 2023;49:107094.
    PubMed     Abstract available
    
    
    
28. ZHOU M, Zhong G, Sun H, Zhu Q, et al
    Risk factors for postoperative pancreatic fistula (POPF) in gastric cancer patients: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2023;49:107092.
    PubMed     Abstract available
    
    
    
29. REIS ME, Ulusahin M, Cekic AB, Usta MA, et al
    Does surgeon specialization add value to surgeon volume in gastric cancer surgery?
    Eur J Surg Oncol. 2023;49:107091.
    PubMed     Abstract available
    
    
    
30. IKEGAME K, Hatakeyama K, Terashima M, Sugino T, et al
    Molecular profiling of gastric neuroendocrine carcinomas.
    Eur J Surg Oncol. 2023;49:106987.
    PubMed     Abstract available
    
    
    
31. LUIJTEN JCHBM, Vissers PAJ, Geerts J, Lemmens VEP, et al
    Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting.
    Eur J Surg Oncol. 2023;49:106880.
    PubMed     Abstract available
    
    
    
32. LIN X, Tan C, Li Z, Wu W, et al
    Long-term oncologic and surgical outcomes of robotic and laparoscopic gastrectomy for Siewert II/III esophagogastric junction carcinoma: A propensity score-matched retrospective cohort study.
    Eur J Surg Oncol. 2023;49:106898.
    PubMed     Abstract available
    
    
    
33. FUNK-DEBLEDS P, Rossi J, Bernard L, Galan A, et al
    Post-operative weight loss affects 3-year survival in patients with gastric adenocarcinoma after gastrectomy and hyperthermic intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2023;49:106895.
    PubMed     Abstract available
    
    
    August 2023
34. DE JONGH C, Triemstra L, van der Veen A, Brosens LA, et al
    Surgical quality and prospective quality control of the D2-gastrectomy for gastric cancer in the multicenter randomized LOGICA-trial.
    Eur J Surg Oncol. 2023;49:107018.
    PubMed     Abstract available
    
    
    June 2023
35. BIONDI A, Lorenzon L, Santoro G, Agnes A, et al
    Profiling complete regression after pre-operative therapy in gastric cancer patients using clinical and pathological data.
    Eur J Surg Oncol. 2023 Jun 30:S0748-7983(23)00561.
    PubMed     Abstract available
    
    
    March 2023
36. HERRERA-KOK JH, Parmar C, Bangash AH, Samadov E, et al
    Global impact of COVID-19 pandemic on gastric cancer patients.
    Eur J Surg Oncol. 2023 Mar 2:S0748-7983(23)00170.
    PubMed    
    
    
    January 2023
37. JANG A, Jeong O
    The impact of the 30-day postoperative complications on the quality of life following gastrectomy for gastric carcinoma: A prospective study.
    Eur J Surg Oncol. 2023 Jan 18:S0748-7983(23)00083.
    PubMed     Abstract available
    
    
    
38. ZHENG HL, Lin J, Shen LL, Yang HB, et al
    The GLIM criteria as an effective tool for survival prediction in gastric cancer patients.
    Eur J Surg Oncol. 2023 Jan 12:S0748-7983(23)00031.
    PubMed     Abstract available
    
    
    
39. KROESE TE, van Rossum PSN, Nilsson M, Lordick F, et al
    Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer.
    Eur J Surg Oncol. 2023;49:21-28.
    PubMed     Abstract available
    
    
    
40. LEIJONMARCK W, Asplund J, Markar SR, Mattsson F, et al
    Weekday of gastrectomy and long-term survival in gastric adenocarcinoma.
    Eur J Surg Oncol. 2023;49:83-88.
    PubMed     Abstract available
    
    
    
41. KUMAZU Y, Hasegawa S, Hayashi T, Yamada T, et al
    Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?
    Eur J Surg Oncol. 2023;49:76-82.
    PubMed     Abstract available
    
    
    December 2022
42. KUBO N, Cho H, Lee D, Yang H, et al
    Risk prediction model of peritoneal seeding in advanced gastric cancer: A decision tool for diagnostic laparoscopy.
    Eur J Surg Oncol. 2022 Dec 26:S0748-7983(22)01359.
    PubMed     Abstract available
    
    
    
43. XU R, Zhang Y, Zhao J, Chen K, et al
    Prognostic value of tumor deposits in lymph node-negative gastric cancer: A propensity score matching study.
    Eur J Surg Oncol. 2022 Dec 14:S0748-7983(22)01350.
    PubMed     Abstract available
    
    
    November 2022
44. TORIUMI T, Terashima M, Mizusawa J, Sato Y, et al
    Recurrence patterns after curative gastrectomy for pStage II/III gastric cancer: Exploratory analysis of the randomized controlled JCOG1001 trial.
    Eur J Surg Oncol. 2022 Nov 16:S0748-7983(22)00821.
    PubMed     Abstract available
    
    
    September 2022
45. JERICO C, Puertolas N, Osorio J, Miranda C, et al
    Cost analysis of a patient blood management program for patients undergoing gastric cancer surgery.
    Eur J Surg Oncol. 2022 Sep 20. pii: S0748-7983(22)00658.
    PubMed     Abstract available
    
    
    
46. CHEN WZ, Yu DY, Zhang XZ, Zhang FM, et al
    Comparison of laparoscopic and open radical gastrectomy for gastric cancer patients with GLIM-defined malnutrition.
    Eur J Surg Oncol. 2022 Sep 17. pii: S0748-7983(22)00676.
    PubMed     Abstract available
    
    
    
47. NAGASAWA S, Sato T, Morita J, Kondo H, et al
    Solitary living worsens the continuation of adjuvant chemotherapy for gastric cancer.
    Eur J Surg Oncol. 2022 Sep 9. pii: S0748-7983(22)00654.
    PubMed     Abstract available
    
    
    
48. NISHIO S, Matsuo K, Nasu H, Murotani K, et al
    Analysis of postoperative adjuvant therapy in 102 patients with gastric-type mucinous carcinoma of the uterine cervix: A multi-institutional study.
    Eur J Surg Oncol. 2022;48:2039-2044.
    PubMed     Abstract available
    
    
    
49. DIJKSTERHUIS WPM, Kroese TE, Verhoeven RHA, van Rossum PSN, et al
    A population-based study on treatment and outcomes in patients with gastric adenocarcinoma diagnosed with distant interval metastases.
    Eur J Surg Oncol. 2022;48:1964-1971.
    PubMed     Abstract available
    
    
    August 2022
50. LI Y, Chen X, Ma X, Lu X, et al
    Computed tomography in the size measurement of gastric gastrointestinal stromal tumors: Implication to risk stratification and "wait-and-see" tactics.
    Eur J Surg Oncol. 2022;48:1739-1745.
    PubMed     Abstract available
    
    
    July 2022
51. CHEN QY, Que SJ, Chen JY, Qing-Zhong, et al
    Development and validation of metabolic scoring to individually predict prognosis and monitor recurrence early in gastric cancer: A large-sample analysis.
    Eur J Surg Oncol. 2022 Jul 14. pii: S0748-7983(22)00521.
    PubMed     Abstract available
    
    
    
52. HAJJAR R, Mercier F, Passot G, Pasquer A, et al
    Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for small bowel neuroendocrine tumors with peritoneal metastasis.
    Eur J Surg Oncol. 2022;48:1626-1630.
    PubMed     Abstract available
    
    
    June 2022
53. WANG L, Lv P, Xue Z, Chen L, et al
    Novel CT based clinical nomogram comparable to radiomics model for identification of occult peritoneal metastasis in advanced gastric cancer.
    Eur J Surg Oncol. 2022 Jun 30. pii: S0748-7983(22)00539.
    PubMed     Abstract available
    
    
    
54. CHEN Y, Sun R, Liu W
    Impact of a previous cancer history on the overall survival of patients with primary gastric cancer: A SEER population-based study.
    Eur J Surg Oncol. 2022 Jun 20. pii: S0748-7983(22)00524.
    PubMed     Abstract available
    
    
    
55. CHEN JY, Lin GT, Chen QY, Zhong Q, et al
    Textbook outcome, chemotherapy compliance, and prognosis after radical gastrectomy for gastric cancer: A large sample analysis.
    Eur J Surg Oncol. 2022 Jun 9. pii: S0748-7983(22)00475.
    PubMed     Abstract available
    
    
    
56. SONG JH, Shin HJ, Lee S, Park SH, et al
    No detrimental effect of perioperative blood transfusion on recurrence in 2905 stage II/III gastric cancer patients: A propensity-score matching analysis.
    Eur J Surg Oncol. 2022 Jun 1. pii: S0748-7983(22)00476.
    PubMed     Abstract available
    
    
    May 2022
57. JEONG SA, Yoo MW, Lee IS, Gong CS, et al
    Comparing surgical and oncologic outcomes between laparoscopic gastrectomy and open gastrectomy in advanced gastric cancer with serosal invasion: A retrospective study with propensity score matching.
    Eur J Surg Oncol. 2022 May 23. pii: S0748-7983(22)00464.
    PubMed     Abstract available
    
    
    
58. ARGILLANDER TE, Festen S, van der Zaag-Loonen HJ, de Graeff P, et al
    Outcomes of surgical treatment of non-metastatic gastric cancer in patients aged 70 and older: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2022 May 16. pii: S0748-7983(22)00428.
    PubMed     Abstract available
    
    
    
59. EVANS RP, Kamarajah SK, Kunene V, Zardo D, et al
    Impact of neoadjuvant chemotherapy on nodal regression and survival in oesophageal adenocarcinoma.
    Eur J Surg Oncol. 2022;48:1001-1010.
    PubMed     Abstract available
    
    
    
60. SPOLVERATO G, Azzolina D, Paro A, Lorenzoni G, et al
    Dynamic Prediction of Survival after Curative Resection of Gastric Adenocarcinoma: A landmarking-based analysis.
    Eur J Surg Oncol. 2022;48:1025-1032.
    PubMed     Abstract available
    
    
    April 2022
61. LEE TY, Hsu CH, Fan HL, Liao GS, et al
    Prophylactic hyperthermic intraperitoneal chemotherapy for patients with clinical T4 gastric cancer.
    Eur J Surg Oncol. 2022 Apr 27. pii: S0748-7983(22)00413.
    PubMed     Abstract available
    
    
    March 2022
62. HAYASHI T, Yoshikawa T
    Reply to: Letter to the Editor "Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for the patients diagnosed as pT1b gastric cancer by endoscopic resection".
    Eur J Surg Oncol. 2022 Mar 25. pii: S0748-7983(22)00155.
    PubMed    
    
    
    
63. MATSUI R, Rifu K, Watanabe J, Inaki N, et al
    Letter to the Editor "Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for patients diagnosed with pT1b gastric cancer via endoscopic resection".
    Eur J Surg Oncol. 2022 Mar 19. pii: S0748-7983(22)00132.
    PubMed    
    
    
    
64. DENG H, Qin X
    Comment on Granieri et al. "Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials".
    Eur J Surg Oncol. 2022 Mar 12. pii: S0748-7983(22)00122.
    PubMed    
    
    
    
65. LU J, Wu D, Chen S, Huang JB, et al
    A novel hematological classifier predicting chemotherapy benefit and recurrence hazard for locally advanced gastric cancer A multicenter IPTW analysis.
    Eur J Surg Oncol. 2022 Mar 5. pii: S0748-7983(22)00044.
    PubMed     Abstract available
    
    
    
66. KAMIYA A, Yoshikawa T, Sakon R, Ishizu K, et al
    Optimal surgery and lymph node metastasis of duodenal bulbar neuroendocrine neoplasms.
    Eur J Surg Oncol. 2022;48:597-603.
    PubMed     Abstract available
    
    
    
67. VAN DER WIELEN N, Daams F, Rosati R, Parise P, et al
    Health related quality of life following open versus minimally invasive total gastrectomy for cancer: Results from a randomized clinical trial.
    Eur J Surg Oncol. 2022;48:553-560.
    PubMed     Abstract available
    
    
    February 2022
68. QIU WW, Chen QY, Zheng WZ, He QC, et al
    Postoperative follow-up for gastric cancer needs to be individualized according to age, tumour recurrence pattern, and recurrence time.
    Eur J Surg Oncol. 2022 Feb 25. pii: S0748-7983(22)00119.
    PubMed     Abstract available
    
    
    
69. AMROUN K, Scholer V, Djerada Z, Renard Y, et al
    Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis.
    Eur J Surg Oncol. 2022;48:455-461.
    PubMed     Abstract available
    
    
    
70. CHOI M, Ishizawa S, Kraemer D, Sasson A, et al
    Perioperative chemotherapy versus adjuvant chemotherapy strategies in resectable gastric and gastroesophageal cancer: A Markov decision analysis.
    Eur J Surg Oncol. 2022;48:403-410.
    PubMed     Abstract available
    
    
    
71. OH SE, Lee GH, An JY, Lee JH, et al
    Comparison of transabdominal and transthoracic surgical approaches in the treatment of Siewert type II esophagogastric junction cancers: A propensity score-matching analysis.
    Eur J Surg Oncol. 2022;48:370-376.
    PubMed     Abstract available
    
    
    
72. LUIJTEN JCHBM, Nieuwenhuijzen GAP, Sosef MN, de Hingh IHJT, et al
    Impact of nationwide centralization of oesophageal, gastric, and pancreatic surgery on travel distance and experienced burden in the Netherlands.
    Eur J Surg Oncol. 2022;48:348-355.
    PubMed     Abstract available
    
    
    
73. HAYASHI T, Yoshikawa T, Ishizu K, Tsutsui M, et al
    Suprapancreatic nodal dissection should not be uniformly selected in additional gastrectomy for the patients who diagnosed as pT1b gastric cancer by endoscopic resection.
    Eur J Surg Oncol. 2022 Feb 1. pii: S0748-7983(22)00072.
    PubMed     Abstract available
    
    
    January 2022
74. SOLAINI L, Bencivenga M, D'ignazio A, Milone M, et al
    Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study.
    Eur J Surg Oncol. 2022 Jan 22. pii: S0748-7983(22)00046.
    PubMed     Abstract available
    
    
    
75. TERASHIMA M, Sano T, Mizusawa J, Umemura K, et al
    Prediction of the peritoneal recurrence via the macroscopic diagnosis of the serosal invasion in patients with gastric cancer: Supplementary analysis of JCOG0110.
    Eur J Surg Oncol. 2022 Jan 19. pii: S0748-7983(22)00040.
    PubMed     Abstract available
    
    
    
76. YASUFUKU I, Ohashi M, Makuuchi R, Hayami M, et al
    High prevalence of peritoneal metastasis in gastric cancer presenting gastric outlet obstruction: A new candidate for consecutive diagnostic staging laparoscopy and laparoscopic gastrojejunostomy.
    Eur J Surg Oncol. 2022 Jan 11. pii: S0748-7983(22)00012.
    PubMed     Abstract available
    
    
    
77. TAKEBAYASHI K, Murata S, Kodama H, Kaida S, et al
    Long-term prognosis of patients with cancer-related genes detected in postoperative peritoneal washings obtained during curative gastrectomy.
    Eur J Surg Oncol. 2022;48:177-182.
    PubMed     Abstract available
    
    
    December 2021
78. CERO MD, Rodriguez-Santiago J, Miro M, Castro S, et al
    Evaluation of data quality in the Spanish EURECCA Esophagogastric Cancer Registry.
    Eur J Surg Oncol. 2021;47:3081-3087.
    PubMed     Abstract available
    
    
    November 2021
79. QIU Y, Zhang X, Deng X, Zhang R, et al
    Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy.
    Eur J Surg Oncol. 2021 Nov 21. pii: S0748-7983(21)00924.
    PubMed     Abstract available
    
    
    
80. HUANG SF, Chen TC, Hsu JT, Tsai CY, et al
    Lymph node micrometastasis of poorly differentiated node-negative gastric cancer risks a worse-than-expected survival outcome under standard management algorithm.
    Eur J Surg Oncol. 2021 Nov 19. pii: S0748-7983(21)00926.
    PubMed     Abstract available
    
    
    
81. DAL CERO M, Roman M, Grande L, Yarnoz C, et al
    Textbook outcome and survival after gastric cancer resection with curative intent: A population-based analysis.
    Eur J Surg Oncol. 2021 Nov 2. pii: S0748-7983(21)00775.
    PubMed     Abstract available
    
    
    September 2021
82. ROVIELLO F, Marano L, Ambrosio MR, Resca L, et al
    Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival.
    Eur J Surg Oncol. 2021 Sep 7. pii: S0748-7983(21)00726.
    PubMed     Abstract available
    
    
    August 2021
83. JAVANBAKHT M, Mashayekhi A, Branagan-Harris M, Horvath P, et al
    Cost-effectiveness analysis of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with gastric cancer and peritoneal metastasis.
    Eur J Surg Oncol. 2021 Aug 28. pii: S0748-7983(21)00696.
    PubMed     Abstract available
    
    
    
84. PARK JH, Berlth F, Wang C, Wang S, et al
    Mapping of the perigastric lymphatic network using indocyanine green fluorescence imaging and tissue marking dye in clinically advanced gastric cancer.
    Eur J Surg Oncol. 2021 Aug 27. pii: S0748-7983(21)00701.
    PubMed     Abstract available
    
    
    
85. ZHANG FM, Zhang XZ, Zhu GL, Lv LQ, et al
    Impact of sarcopenia on clinical outcomes of patients with stage I gastric cancer after radical gastrectomy: A prospective cohort study.
    Eur J Surg Oncol. 2021 Aug 17. pii: S0748-7983(21)00693.
    PubMed     Abstract available
    
    
    
86. SEDLAK K, Rawicz-Pruszynski K, Mlak R, Geca K, et al
    Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients.
    Eur J Surg Oncol. 2021 Aug 11. pii: S0748-7983(21)00674.
    PubMed     Abstract available
    
    
    
87. RI M, Yamashita H, Gonoi W, Okumura Y, et al
    Identifying multiple swollen lymph nodes on preoperative computed tomography is associated with poor prognosis along with pathological extensive nodal metastasis in locally advanced gastric cancer.
    Eur J Surg Oncol. 2021 Aug 10. pii: S0748-7983(21)00687.
    PubMed     Abstract available
    
    
    
88. BORGSTEIN ABJ, Keywani K, Eshuis WJ, van Berge Henegouwen MI, et al
    Staging laparoscopy in patients with advanced gastric cancer: A single center cohort study.
    Eur J Surg Oncol. 2021 Aug 8. pii: S0748-7983(21)00672.
    PubMed     Abstract available
    
    
    
89. CHALLINE A, Voron T, Dousset B, Creavin B, et al
    Postoperative outcomes after laparoscopic or open gastrectomy. A national cohort study of 10,343 patients.
    Eur J Surg Oncol. 2021;47:1985-1995.
    PubMed     Abstract available
    
    
    
90. ZOU HB, Yan XL, Dong WX, Yu DY, et al
    Sarcopenia is a predictive factor of poor quality of life and prognosis in patients after radical gastrectomy.
    Eur J Surg Oncol. 2021;47:1976-1984.
    PubMed     Abstract available
    
    
    
91. YAMAGATA Y, Yoshikawa T, Ishizu K, Kamiya A, et al
    Is lymph node dissection for neuroendocrine carcinoma of the stomach effective as it is for adenocarcinoma?
    Eur J Surg Oncol. 2021;47:2004-2009.
    PubMed     Abstract available
    
    
    
92. HAYASHI M, Fujita T, Matsushita H
    Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies.
    Eur J Surg Oncol. 2021;47:1996-2003.
    PubMed     Abstract available
    
    
    July 2021
93. CHEN Y, Yuan F, Wang L, Li E, et al
    Evaluation of dual-energy CT derived radiomics signatures in predicting outcomes in patients with advanced gastric cancer after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2021 Jul 20. pii: S0748-7983(21)00635.
    PubMed     Abstract available
    
    
    
94. WADA T, Yoshikawa T, Sekine S, Kamiya A, et al
    Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2021 Jul 17. pii: S0748-7983(21)00637.
    PubMed     Abstract available
    
    
    
95. KACMAZ E, Slooter MD, Nieveen van Dijkum EJM, Tanis PJ, et al
    Fluorescence angiography guided resection of small bowel neuroendocrine neoplasms with mesenteric lymph node metastases.
    Eur J Surg Oncol. 2021;47:1611-1615.
    PubMed     Abstract available
    
    
    June 2021
96. ROH CK, Hyung WJ
    Reply to: Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre'.
    Eur J Surg Oncol. 2021 Jun 9. pii: S0748-7983(21)00543.
    PubMed    
    
    
    
97. CARBONI F, Valle M
    Letter to Roh CK et al. 'Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre'.
    Eur J Surg Oncol. 2021 Jun 5. pii: S0748-7983(21)00544.
    PubMed    
    
    
    
98. BARCOT O, Boric M, Cavar M, Poropat G, et al
    Predictive value of abdominal drain amylase for postoperative pancreatic fistula following gastric resection: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2021;47:1244-1251.
    PubMed     Abstract available
    
    
    May 2021
99. GRANIERI S, Bonomi A, Frassini S, Chierici AP, et al
    Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2021 May 11. pii: S0748-7983(21)00492.
    PubMed     Abstract available
    
    
    April 2021
100. LIN YC, Lin G, Yeh TS
     Visceral-to-subcutaneous fat ratio independently predicts the prognosis of locally advanced gastric cancer----- highlighting the role of adiponectin receptors and PPARalpha, beta/ delta, .
     Eur J Surg Oncol. 2021 Apr 26. pii: S0748-7983(21)00456.
     PubMed     Abstract available
     
     
     
101. OH YJ, Kim DH, Han WH, Eom BW, et al
     Risk factors for lymph node metastasis in early gastric cancer without lymphatic invasion after endoscopic submucosal dissection.
     Eur J Surg Oncol. 2021 Apr 26. pii: S0748-7983(21)00457.
     PubMed     Abstract available
     
     
     
102. KANO Y, Ohashi M, Muneoka Y, Takahari D, et al
     Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy.
     Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00446.
     PubMed     Abstract available
     
     
     
103. FAIZ Z, Hayashi T, Yoshikawa T
     Lymph node dissection for gastric cancer: Establishment of D2 and the current position of splenectomy in Europe and Japan.
     Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00447.
     PubMed     Abstract available
     
     
     
104. KIM DG, Seo WJ, Cho M, Kim YM, et al
     Perioperative, short-, and long-term outcomes of gastric cancer surgery: Propensity score-matched analysis of patients with or without prior solid organ transplantation.
     Eur J Surg Oncol. 2021 Apr 21. pii: S0748-7983(21)00445.
     PubMed     Abstract available
     
     
     
105. CHEN XD, He FQ, Liao MS, Chen M, et al
     Laparoscopic versus open transhiatal approach for adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2021;47:778-788.
     PubMed     Abstract available
     
     
     March 2021
106. BOLGER JC, Al Azzawi M, Whooley J, Bolger EM, et al
     Surgery by a minimally invasive approach is associated with improved textbook outcomes in oesophageal and gastric cancer.
     Eur J Surg Oncol. 2021 Mar 17. pii: S0748-7983(21)00381.
     PubMed     Abstract available
     
     
     
107. LEE KG, Shin CI, Kim SG, Choi J, et al
     Can endoscopic ultrasonography (EUS) improve the accuracy of clinical T staging by computed tomography (CT) for gastric cancer?
     Eur J Surg Oncol. 2021 Mar 10. pii: S0748-7983(21)00125.
     PubMed     Abstract available
     
     
     
108. HUANG DD, Yu DY, Song HN, Wang WB, et al
     The relationship between the GLIM-defined malnutrition, body composition and functional parameters, and clinical outcomes in elderly patients undergoing radical gastrectomy for gastric cancer.
     Eur J Surg Oncol. 2021 Mar 6. pii: S0748-7983(21)00126.
     PubMed     Abstract available
     
     
     February 2021
109. ROH CK, Choi S, Seo WJ, Cho M, et al
     Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre.
     Eur J Surg Oncol. 2021 Feb 25. pii: S0748-7983(21)00104.
     PubMed     Abstract available
     
     
     
110. MURNANE LC, Forsyth AK, Koukounaras J, Pilgrim CH, et al
     Myosteatosis predicts higher complications and reduced overall survival following radical oesophageal and gastric cancer surgery.
     Eur J Surg Oncol. 2021 Feb 19. pii: S0748-7983(21)00099.
     PubMed     Abstract available
     
     
     
111. WEN L, Yu K, Lu H, Zhong G, et al
     Impact of prior cancer history on survival of patients with gastric cancer.
     Eur J Surg Oncol. 2021 Feb 11. pii: S0748-7983(21)00090.
     PubMed     Abstract available
     
     
     
112. XING J, Wang Y, Shan F, Li S, et al
     Comparison of totally laparoscopic and laparoscopic assisted gastrectomy after neoadjuvant chemotherapy in locally advanced gastric cancer.
     Eur J Surg Oncol. 2021 Feb 6. pii: S0748-7983(21)00085.
     PubMed     Abstract available
     
     
     January 2021
113. KOSEKI Y, Hikage M, Fujiya K, Kamiya S, et al
     Utility of a modified age-adjusted Charlson Comorbidity Index in predicting cause-specific survival among patients with gastric cancer.
     Eur J Surg Oncol. 2021 Jan 30. pii: S0748-7983(21)00056.
     PubMed     Abstract available
     
     
     December 2020
114. JI ZH, Yu Y, Liu G, Zhang YB, et al
     Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
     Eur J Surg Oncol. 2020 Dec 1. pii: S0748-7983(20)31035.
     PubMed     Abstract available
     
     
     
115. KOEMANS WJ, van Sandick JW, Huitema ADR
     Reply to: Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy".
     Eur J Surg Oncol. 2020;46:2343.
     PubMed    
     
     
     November 2020
116. OSORIO J, Jerico C, Miranda C, Santamaria M, et al
     Improved postoperative outcomes and reduced transfusion rates after implementation of a Patient Blood Management program in gastric cancer surgery.
     Eur J Surg Oncol. 2020 Nov 27. pii: S0748-7983(20)31025.
     PubMed     Abstract available
     
     
     
117. KINOSHITA T, Sato R, Akimoto E, Yoshida M, et al
     Can laparoscopic spleen-preserving splenic hilar lymph node dissection replace prophylactic splenectomy for proximal advanced gastric cancers that invade the greater curvature?
     Eur J Surg Oncol. 2020 Nov 26. pii: S0748-7983(20)31029.
     PubMed     Abstract available
     
     
     
118. WANG L, Gong J, Huang X, Lin G, et al
     CT-based radiomics nomogram for preoperative prediction of No.10 lymph nodes metastasis in advanced proximal gastric cancer.
     Eur J Surg Oncol. 2020 Nov 24. pii: S0748-7983(20)31028.
     PubMed     Abstract available
     
     
     
119. BORGSTEIN ABJ, van Berge Henegouwen MI, Lameris W, Eshuis WJ, et al
     Staging laparoscopy in gastric cancer surgery. A population-based cohort study in patients undergoing gastrectomy with curative intent.
     Eur J Surg Oncol. 2020 Nov 17. pii: S0748-7983(20)30903.
     PubMed     Abstract available
     
     
     October 2020
120. NISHIWAKI N, Irino T, Fujiya K, Kamiya S, et al
     Extra-nodal metastasis should be classified separately from lymph node metastasis in gastric cancer.
     Eur J Surg Oncol. 2020 Oct 23. pii: S0748-7983(20)30860.
     PubMed     Abstract available
     
     
     
121. GERTSEN EC, Brenkman HJF, Brosens LAA, Luijten JCHBM, et al
     Refraining from resection in patients with potentially curable gastric carcinoma.
     Eur J Surg Oncol. 2020 Oct 22. pii: S0748-7983(20)30862.
     PubMed     Abstract available
     
     
     
122. BENCIVENGA M, Torroni L, Verlato G, Mengardo V, et al
     Lymphadenectomy for gastric cancer at European specialist centres.
     Eur J Surg Oncol. 2020 Oct 15. pii: S0748-7983(20)30845.
     PubMed     Abstract available
     
     
     
123. BRANDL A, Yonemura Y, Glehen O, Sugarbaker P, et al
     Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: A multi-institutional cohort from PSOGI.
     Eur J Surg Oncol. 2020 Oct 14. pii: S0748-7983(20)30839.
     PubMed     Abstract available
     
     
     
124. ZHANG Z, Cheng S, Gong J, Lu M, et al
     Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
125. REN C, Xu RH
     The drug treatment research of gastrointestinal cancer in China.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     August 2020
126. WEINDELMAYER J, Mengardo V, Veltri A, Torroni L, et al
     Should we still use prophylactic drain in gastrectomy for cancer? A systematic review and meta-analysis.
     Eur J Surg Oncol. 2020;46:1396-1403.
     PubMed     Abstract available
     
     
     
127. DEFTEREOS I, Kiss N, Isenring E, Carter VM, et al
     A systematic review of the effect of preoperative nutrition support on nutritional status and treatment outcomes in upper gastrointestinal cancer resection.
     Eur J Surg Oncol. 2020;46:1423-1434.
     PubMed     Abstract available
     
     
     June 2020
128. FUJIYA K, Ohshima K, Kitagawa Y, Hatakeyama K, et al
     Aberrant expression of Wnt/beta-catenin signaling pathway genes in aggressive malignant gastric gastrointestinal stromal tumors.
     Eur J Surg Oncol. 2020;46:1080-1087.
     PubMed     Abstract available
     
     
     April 2020
129. ARCHID R, Zieker D, Weinreich FJ, Hones F, et al
     shRNA-mediated inhibition of PhosphoGlycerate Kinase 1 (PGK1) enhances cytotoxicity of intraperitoneal chemotherapy in peritoneal metastasis of gastric origin.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
130. WANG C, Gao Z, Shen K, Cao J, et al
     Safety and efficiency of endoscopic resection versus laparoscopic resection in gastric gastrointestinal stromal tumours: A systematic review and meta-analysis.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
131. BHATT A, Yonemura Y, Mehta S, Benzerdjeb N, et al
     Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     
     
132. SOMASHEKHAR SP, Yethadka R, Kumar C R, Ashwin KR, et al
     Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
     Eur J Surg Oncol. 2020;46.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.